Please select the option that best describes you:

What is your preferred third-line therapy for metastatic colon cancer, RAS-WT, MSS, low TMB, with no targetable alterations?   

Are you using fruquintinib, regorafinib, or trifluridine + tipiracil + bev?



Answer from: Medical Oncologist at Community Practice
Sign in or Register to read more